ARTV vs MSFT: Which Stock is Better?
Side-by-side comparison of Artiva Biotherapeutics, Inc. Common Stock and Microsoft Corporation in 2026
ARTV
Artiva Biotherapeutics, Inc. Common Stock
$11.28
MSFT
Microsoft Corporation
$499.32
Key Metrics Comparison
| Metric | ARTV | MSFT | Winner |
|---|---|---|---|
| Market Cap | $37.28M | $3.71T | MSFT |
| P/E Ratio | N/A | 33.89 | MSFT |
| EPS (TTM) | $N/A | $14.08 | MSFT |
| Revenue Growth | 0.0% | 18.4% | MSFT |
| Gross Margin | 0.0% | 67.9% | MSFT |
Analyze ARTV
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ARTV or MSFT a better investment?
Comparing ARTV and MSFT: Artiva Biotherapeutics, Inc. Common Stock has a market cap of $37.28M while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ARTV and MSFT?
ARTV (Artiva Biotherapeutics, Inc. Common Stock) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ARTV or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ARTV or MSFT?
MSFT has higher revenue growth at 18.4% vs 0.0% for ARTV.
Which company is more profitable: ARTV or MSFT?
Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for ARTV.
Which is the larger company: ARTV or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $37.28M for ARTV.
Should I buy ARTV or MSFT in 2026?
Both ARTV and MSFT have investment merit. ARTV trades at $11.28 while MSFT trades at $499.32. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ARTV and MSFT stock?
Key differences: Market Cap ($37.28M vs $3.71T), P/E Ratio (N/A vs 33.9x), Revenue Growth (0.0% vs 18.4%), Gross Margin (0.0% vs 67.9%).
Should I buy ARTV or MSFT in 2026?
The choice between ARTV and MSFT depends on your investment goals. MSFT shows higher revenue growth (18.4%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between ARTV and MSFT?
ARTV (Artiva Biotherapeutics, Inc. Common Stock) has a market cap of $37.28M, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.